Amyris Inc Second Virtual Investor Mini-Series Webinar Transcript
Good morning, and welcome to the Amyris Virtual Investor Mini-Series Part II. (Operator Instructions) Please note this event is being recorded. You may listen to a webcast replay of this call by going to the Investors section of Amyris' website. I would now like to turn the conference over to Han Kieftenbeld, Chief Financial Officer of Amyris. Please go ahead.
Thank you, operator, and good morning and good afternoon. With me today from Amyris are John Melo, President and Chief Executive Officer; Daya Fields, President, Pipette and Purecane; Catherine Gore, President, Biossance; Caroline Hadfield, Chief Executive Officer, Rose Inc., and President, Aprinnova; Sheila Shekar Pollak, Chief Marketing Officer of Biossance; and our guest, Julian Reis, Founder and Chief Executive Officer of SuperOrdinary. Today's webcast is the second session in the Amyris Virtual Investor Mini-Series after a very well-attended first session on December 15. The theme for the series is Delivering on the Promise of Synthetic Biology.
Today
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
